<DOC>
	<DOCNO>NCT00646204</DOCNO>
	<brief_summary>To evaluate effect Memantine non-motor symptom patient Parkinson 's disease . Parkinson 's disease ( PD ) affect one million people United States . It common neurological condition clinically define rigidity ( muscle stiffness ) , bradykinesia ( slowness movement ) tremor . Parkinson 's Disease , however , reveals numerous non-motor symptom underemphasized . Problematic symptom include vary degree dementia , psychosis , diminish assertiveness confidence , general fatigue , excessive daytime sleepiness , problem blood pressure , sweating , bladder , common yet difficult define sense `` feeling well '' .</brief_summary>
	<brief_title>Namenda ( Memantine ) Non-Motor Symptoms Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>1 . Subjects must age 18 80 inclusive . 2 . Each subject must meet standard criterion PD . 3 . All patient dopaminergic therapy must report benefit . No abnormal neurological sign . No direct indirect trauma nervous system within 3 month precede onset PD . No convincing evidence sudden onset evidence stepwise deterioration . 4 . Subjects must generally good health evidence previous medical history clinical examination . 5 . Subjects allow take PD medication exception amantadine . They also allow take medication approve use Alzheimer 's disease . 6 . Subjects require stable dose medication least two week prior entry study may alter medication throughout study . 7 . If subject antidepressant medication , stable dose require least six week prior entry study . 8 . Subjects must accessible telephone . 9 . If subject female childbearing age , must : hysterectomy , tubal ligation , otherwise incapable pregnancy , practice one follow method contraception least one month prior study entry : hormonal contraceptive , spermicide barrier , intrauterine device , partner sterility . 10 . Female childbearing age must negative urine pregnancy test within one week study entry . 11 . Prior participation study , subject must sign informed consent . 1 . Subjects meet inclusion criterion . 2 . Subjects able abstain alcohol 24 hour prior evaluation . 3 . Subjects maintain identical dose medicine may affect PD symptom sign entire study involvement . 4 . Subjects exhibit meaningful psychiatric disease think related PD . ( Depression psychosis typical PD exclude ) . 5 . Subjects previously take memantine . 6 . Subjects currently take Amantadine . 7 . Subjects great moderate dementia ( MMSE &lt; 24 ) . 8 . Subjects comorbid disease investigator decision could interfere treatment memantine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>non-motor symptom</keyword>
</DOC>